Literature DB >> 10648041

Evaluation of the relationship between depression and fibromyalgia syndrome: why aren't all patients depressed?

A Okifuji1, D C Turk, J J Sherman.   

Abstract

OBJECTIVE: To examine the relationship between fibromyalgia syndrome (FM) and depression by determining the set of factors that differentiate FM patients with and without depressive disorders.
METHODS: A sample of 69 patients with FM underwent a standardized tender point examination and a semistructured psychological interview and completed a set of self-report inventories.
RESULTS: Of the sample, 39 met criteria for depressive disorder and 30 did not. Depressed patients with FM were significantly more likely to live alone, report elevated functional limitations, and display maladaptive thoughts than nondepressed patients. Nondepressed patients were significantly more likely to have received prior physical therapy than depressed patients. Pain severity, numbers of positive tender points, and pain intensity of tender points and control points did not differentiate the depressed and nondepressed patients. Discriminant analysis revealed that living status, the perception of functional limitations, maladaptive thoughts, and physical therapy treatment together identified diagnoses of depressive disorders for 78% of the patients.
CONCLUSION: Concurrent depressive disorders are prevalent in FM and may be independent of the cardinal features of FM, namely, pain severity and hypersensitivity to pressure pain, but are related to the cognitive appraisals of the effects of symptoms on daily life and functional activities.

Entities:  

Mesh:

Year:  2000        PMID: 10648041

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  34 in total

1.  A comparison of quality of life, demographic and clinical characteristics of Brazilian men with fibromyalgia syndrome with male patients with depression.

Authors:  Gilberto Toshimitsu Yoshikawa; Roberto Ezequiel Heymann; Milton Helfenstein; Daniel Feldman Pollak
Journal:  Rheumatol Int       Date:  2009-06-27       Impact factor: 2.631

Review 2.  Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain.

Authors:  Dennis C Turk; Joseph Audette; Robert M Levy; Sean C Mackey; Steven Stanos
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

3.  Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory.

Authors:  Clare J Wilhelm; Bret E Fuller; Marilyn Huckans; Jennifer M Loftis
Journal:  Drug Alcohol Depend       Date:  2017-05-10       Impact factor: 4.492

4.  Sequential analyses of daily symptoms in women with fibromyalgia syndrome.

Authors:  Akiko Okifuji; David H Bradshaw; Gary W Donaldson; Dennis C Turk
Journal:  J Pain       Date:  2010-07-01       Impact factor: 5.820

5.  The Complex Relationship between Pain Intensity and Physical Functioning in Fibromyalgia: The Mediating Role of Depression.

Authors:  Jennifer L Steiner; Silvia M Bigatti; James E Slaven; Dennis C Ang
Journal:  J Appl Biobehav Res       Date:  2017-04-20

6.  The use of PRIME-MD questionnaire in a rheumatology clinic.

Authors:  A S Russell; B K Hui
Journal:  Rheumatol Int       Date:  2004-12-10       Impact factor: 2.631

7.  [Fibromyalgia -- a somatoform (pain) disorder?].

Authors:  W Häuser; K Bernardy; B Arnold
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

Review 8.  Psychological determinants of fibromyalgia and related syndromes.

Authors:  J B Winfield
Journal:  Curr Rev Pain       Date:  2000

9.  The relevance of depressive symptoms and social support to disability in women with multiple sclerosis or fibromyalgia.

Authors:  Lorraine J Phillips; Alexa K Stuifbergen
Journal:  Int J Rehabil Res       Date:  2010-06       Impact factor: 1.479

Review 10.  [Neuroendocrine changes and maladaptations in fibromyalgia. Etiopathogenetic findings].

Authors:  K Thieme
Journal:  Orthopade       Date:  2004-05       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.